A Pilot Study of Anselamimab in Patients With AL Amyloidoma and Measurable Tissue Involvement
Clinical trial NCT07615270 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07615270
- Sponsor
- Stanford University
- Status
- NOT_YET_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-01
- Primary completion
- 2028-07-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.